Lawrence Erik Kurzius, Director at Elanco Animal Health Inc (ELAN), bought 40,000 shares at $23.40 ($936K) on 2026-08-20, disclosed to the SEC on 2026-08-21.
Director Lawrence Erik Kurzius purchased $935,920 worth of Elanco shares at $23.40, marking the largest insider purchase in the company's history. This significant buy signals high confidence from leadership, particularly given the stock's recent pullback despite strong Q2 earnings and product approvals.
The stock is trading at $23.575, down 0.4% over the last 5 days and 6.98% over the last 30 days, but remains up 34.79% over the past year. It is currently 15.68% below its 52-week high of $27.96.
Something here stands out, but not much.
| Filing → |
| MKC | SELL | 2026-08-12 | $10.8M | — | Filing → |
| MKC | SELL | 2026-02-13 | $3.6M | — | Filing → |
| MKC | SELL | 2026-01-14 | $3.4M | — | Filing → |